CVE-2026-123050

Improper TLS Certificate Validation in Farmasimplex Healthcare Integration Modules

Published Nov 17, 2026 CVSS 4.0 · 7.1 High EPSS n/a KEV · Not listed
Description
Multiple Farmasimplex healthcare integration modules do not properly validate TLS certificates, allowing an attacker who can intercept network traffic to impersonate trusted healthcare services and perform man-in-the-middle attacks, potentially leading to disclosure or modification of sensitive data.

Analysis

AI-generated

Technical impact

Farmasimplex healthcare integration modules fail to validate TLS certificates, allowing an attacker who can intercept traffic to impersonate trusted services. This flaw enables a man‑in‑the‑middle attack that can result in the disclosure or modification of sensitive healthcare data. The weakness is an improper record or data validation vulnerability, specifically CWE‑295.

Affected Systems

The affected components are the Farmasimplex healthcare integration modules developed by CIPCarbone. No specific affected versions are listed, so all current installations of these modules are considered vulnerable.

Risk and Exploitability

The CVSS score of 7.1 indicates a moderate‑to‑high severity. An exploiter would need the ability to intercept or redirect traffic between the client and the integration service, a capability usually available to attackers within the same network or on compromised endpoints. Because exposure does not grant code execution and there is no disclosed exploit technique, the likelihood of immediate exploitation is relatively low, but the potential damage to confidentiality and integrity is significant. The vulnerability is not listed in the CISA KEV catalog and EPSS information is unavailable.

Remediation

No solution or workaround provided in the CVE record.

OpenCVE Recommended Actions

  • Deploy the latest Farmasimplex patch that enforces proper TLS certificate validation.
  • Configure all clients and middleware to require strict certificate verification and to reject any self‑signed or mismatched certificates.
  • If a patch is not yet available, segment the network so that integration modules only communicate with known, vetted endpoints and employ monitoring to detect anomalous traffic between the modules and healthcare services.

Generated by OpenCVE AI on November 17, 2026 at 15:23 UTC.

Tracking

Sign in to view the affected projects.

Advisories

No advisories available
History
Type Values Removed Values Added
Description Multiple Farmasimplex healthcare integration modules do not properly validate TLS certificates, allowing an attacker who can intercept network traffic to impersonate trusted healthcare services and perform man-in-the-middle attacks, potentially leading to disclosure or modification of sensitive data.
Title Improper TLS Certificate Validation in Farmasimplex Healthcare Integration Modules
Weaknesses CWE-295
References
Metrics cvssV4_0

{'score': 7.1, 'vector': 'CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:U'}

Subscriptions

No data.

Weaknesses
  • CWE-295

    Improper Certificate Validation

Sources

Status
PUBLISHED
Assigner
ENISA
Published
Updated
Nov 17, 2026, 2:30 PM
Reserved
Nov 5, 2026, 8:44 AM
Status
Received
Published
Nov 17, 2026, 3:17 PM
Modified
Nov 17, 2026, 3:17 PM